- $8.09m
- $10.58m
- $34.07m
- 21
- 55
- 56
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26.2 | 18.8 | 24.1 | 28.7 | 34.1 |
Cost of Revenue | |||||
Gross Profit | 13.8 | 9.78 | 11.4 | 13.5 | 16.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 39.9 | 28.5 | 49.3 | 47.3 | 49.4 |
Operating Profit | -13.7 | -9.61 | -25.2 | -18.6 | -15.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.9 | -10.9 | -37.7 | -0.608 | -20.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11 | -11 | -37.7 | -0.64 | -20.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -11 | -11 | -37.7 | -0.64 | -20.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11 | -11 | -37.7 | -0.64 | -20.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -30 | -25.6 | -67.9 | -0.07 | -15.6 |